Correction: RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling
Zhiguo Niu, Jianing Fan, Fengzhe Chen, Huijie Yang, Xin Li, Ting Zhuang, Chunlei Guo, Qi Cao, Jian Zhu, Hui Wang, Qingsong Huang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Hypoxia, and Metabolism · FOXO transcription factor regulation · Metabolism, Diabetes, and Cancer
Correction to: Cell Death & Disease 10.1038/s41419-022-05473-6, published online 06 December 2022
Since the publication of the aforementioned article, our research team identified errors in the data presented in Fig. 1S and Fig. 1M of the paper during a retrospective review of previous studies. The correct data are provided in the email attachments (TIFF and PPT files). These errors do not affect the main conclusions or the original data of the study, as the experimental trends observed upon RBCK1 depletion are consistent between the corrected figures and the erroneous ones. We sincerely apologize for any inconvenience this may have caused. Our team will take this as a serious lesson, rigorously reviewing all previously published and future work to uphold academic integrity.
Figure 1S original
Figure 1S amended
Figure 1M original
Figure 1M amended
The original article has been corrected.